secwatch / observer
8-K filed February 7, 2024, 6:59 PM ET ticker CVS CIK 0000064803
earnings confidence high sentiment neutral materiality 0.75

CVS Q4 revenue $93.8B (+11.9% YoY), adj. EPS $2.12; FY2024 adj. EPS guidance cut to $8.30

CVS HEALTH Corp

2023-FY EPS reported $6.47 revenue$357,776,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

CVS HEALTH Corp reported three months and year ended December 31, 2023 results: revenue $93.8 billion, EPS GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12. Guidance lowered.

Period
three months and year ended December 31, 2023
Revenue
$93.8 billion
EPS
GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12
Guidance
lowered
Result
reported results
Exact text from the filing
(NYSE: CVS) today announced operating results for the three months and year ended December 31, 2023. FOURTH QUARTER HIGHLIGHTS KEY FINANCIAL DATA • Total revenues increased to $93.8 billion, up 11.9% compared to prior year • GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12 FULL-YEAR HIGHLIGHTS • Total revenues increased to $357.8 billion, up 10.9% compared to
View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

CVS HEALTH Corp filing history →

Source: SEC EDGAR
accession 0000064803-24-000006
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.